Pomalidomide: A new IMiD with remarkable activity in both multiple myeloma and myelofibrosis-Reference-Cited by-同舟云学术

Pomalidomide: A new IMiD with remarkable activity in both multiple myeloma and myelofibrosis

Published:2010-02 Issue:2 Volume:85 Page:95-96
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Lacy Martha Q.,Rajkumar S. Vincent

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.21610/fullpdf

Reference35 articles.

1. Thalidomide is an inhibitor of angiogenesis;D'Amato;Proc Natl Acad Sci USA,1994

2. Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity;Keifer;J Biol Chem,2001

3. Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: Therapeutic implications;Mitsiades;Blood,2002

4. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma;Davies;Blood,2001

5. Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the antitumour activity of rituximab in vivo;Reddy;Br J Haematol,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Validated Chiral Chromatography Method for Enantiomeric Separation of Pomalidomide in Human Plasma;Journal of Chromatographic Science;2024-05-14

2. Immunotherapy of cancer;Nanotechnology Applications for Cancer Chemotherapy;2021

3. Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials;Cancer Letters;2018-10

4. Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure–Degradation Relationships;ChemMedChem;2018-07-04

5. Is there a role for pomalidomide in the treatment of myelofibrosis?;Expert Opinion on Orphan Drugs;2016-04-06